2697 — Guangdong True Health Medical Technology Development Share Price
Last trade - 00:00- HK$2.21bn
- HK$1.66bn
- CNY12.18m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.48 | ||
| Price to Tang. Book | 3.48 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 106.78 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -16.76% | ||
| Return on Equity | -34.56% | ||
| Operating Margin | -526.48% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | n/a | 1.79 | 12.18 | 58.21 | 174.94 | 579.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Guangdong True Health Medical Technology Development Co., Ltd. is a China-based company primarily engaged in developing and commercializing percutaneous puncture and ablation surgical robots. The Company’s core product is percutaneous puncture surgical robot, including four models: TH-S1, TH-S, TH-S pro and TH-SA. The Company’s pipeline also includes the percutaneous microwave ablation surgical robot TH-X MW, the percutaneous microwave ablation surgical robot TH-XHMW, the TH-P series of compact percutaneous puncture surgical robots, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The Company's products are mainly used for lung and abdominal punctures, as well as the treatment of liver and lung tumors.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- March 16th, 2018
- Public Since
- June 30th, 2026
- No. of Employees
- 158
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 35,647,003
- Address
- ZHUHAI
- Web
- http://www.truehealth.cn
- Phone
- Auditors
- Ernst & Young
Similar to 2697
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 05:44 UTC, shares in Guangdong True Health Medical Technology Development are trading at HK$62.10. This share price information is delayed by 15 minutes.
Shares in Guangdong True Health Medical Technology Development last closed at HK$62.10 and the price had moved by over the past 365 days. In terms of relative price strength the Guangdong True Health Medical Technology Development share price has matched the FTSE Developed Asia Pacific Index by over the past year.
The overall consensus recommendation for Guangdong True Health Medical Technology Development is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreGuangdong True Health Medical Technology Development does not currently pay a dividend.
Guangdong True Health Medical Technology Development does not currently pay a dividend.
Guangdong True Health Medical Technology Development does not currently pay a dividend.
To buy shares in Guangdong True Health Medical Technology Development you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$62.10, shares in Guangdong True Health Medical Technology Development had a market capitalisation of HK$2.21bn.
Here are the trading details for Guangdong True Health Medical Technology Development:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2697
Based on an overall assessment of its quality, value and momentum Guangdong True Health Medical Technology Development is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Guangdong True Health Medical Technology Development is HK$449.00. That is 623.03% above the last closing price of HK$62.10.
Analysts covering Guangdong True Health Medical Technology Development currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Guangdong True Health Medical Technology Development. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of HK$62.10, shares in Guangdong True Health Medical Technology Development were trading -86.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Guangdong True Health Medical Technology Development PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$62.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Guangdong True Health Medical Technology Development's directors